July 15, 2026, will be remembered as a watershed moment in India’s economic history. On this day, the India-UK Comprehensive Economic and Trade Agreement (CETA) officially comes into force, marking one of the largest bilateral trade deals India has signed in recent decades.
The numbers are staggering. The UK imported goods worth $928.9 billion from around the world in 2025, yet India’s share was just $15.2 billion—a mere 1.6%. CETA is designed to change that equation fundamentally.
Union Commerce Minister Piyush Goyal captured the moment succinctly: “By securing immediate duty-free access on 99% of our tariff lines, we have systematically dismantled long-standing tariff walls.”
But tariff elimination alone is only half the story. As the Global Trade Research Initiative (GTRI) has cautioned, “Without parallel work on standards, certification, logistics, regulatory approvals and buyer networks, much of the opportunity will remain on paper.”
This article cuts through the noise to analyze the three sectors positioned for the most immediate transformation—Textiles, Gems & Jewellery, and Pharmaceuticals—alongside a detailed breakdown of the “99% duty-free” clause and what it means for India’s SME exporters.
The “99% Duty-Free” Clause: Breaking It Down
What It Actually Means
Under CETA, Indian exporters will receive zero-duty access on approximately 99% of tariff lines, covering nearly 100% of the trade value of India’s current exports to the UK.
To put this in perspective: before CETA, only 48.2% of India’s export value entered Britain at zero duty under the UK’s most-favoured-nation regime. The agreement immediately
expands duty-free coverage to nearly everything India sells to Britain.
Sector-by-Sector Tariff Elimination
The UK has committed to eliminating tariffs across key Indian export categories:
| Sector | Previous Tariff | New Tariff |
|---|---|---|
| Textiles & Garments | Up to 12% | 0% |
| Leather & Footwear | Up to 16% | 0% |
| Chemicals & Pharma | Up to 8% | 0% |
| Engineering & Auto Components | Up to 18% | 0% |
| Marine Products | Up to 21.5% | 0% |
| Processed Foods | Up to 70% | 0% |
| Gems & Jewellery | up to 4% | 0% |
The SME Exporters’ Reality
For India’s micro, small and medium enterprises (MSMEs), CETA represents both a historic opportunity and a formidable challenge.
The Opportunity: SMEs now compete on a level playing field with competitors from Bangladesh, Vietnam and Pakistan, which previously enjoyed preferential tariff access. The agreement opens a UK market worth nearly $929 billion in annual imports. Commerce Minister Goyal has emphasized that the pact will help “Indian farmers, fishermen, artisans and small businesses prosper globally”.
The Challenge: Tariff reduction alone does not guarantee orders. SMEs must now navigate:
· Sustainability standards – Global retailers increasingly demand ethical sourcing and product traceability
· Certification requirements – Meeting British quality and safety norms
· Logistics and delivery timelines – Competing with established supply chains from China and Bangladesh
· Buyer relationships – Building commercial links with UK retailers
As trade experts note, “For MSMEs, which form the backbone of India’s textile sector, the ability to meet these requirements could determine whether the FTA becomes a genuine export opportunity or remains largely untapped.”
The good news? Export orders are already surging. Textile and garment exporters are seeing 12% higher orders from the UK than last year, while leather handbag and shoe orders are up 20%. Gems and jewellery consignments worth $6.5 million are ready for shipment.
Sector 1: Textiles & Apparel – The Immediate Winner
Why Textiles Lead the Pack
Textiles and apparel represent the clearest immediate beneficiary of CETA. The agreement eliminates UK tariffs of up to 12% on textile imports from India.
The scale of the opportunity is immense:
· The UK imported $21.3 billion worth of garments in 2025
· India supplied only $1.3 billion of that—just 6% of the UK’s garment imports
· India exported $16.3 billion worth of garments globally in 2025
Elara Capital’s Prerna Jhunjhunwala puts it simply: “We will be in a position to gain market share, given the level playing field now with competing countries like Bangladesh, Pakistan and Vietnam.”
Key Beneficiaries
S.P. Apparels (NSEI: SPAL)
· Tirupur-based manufacturer and exporter of knitted garments
· Derives nearly 50% of its revenue from the UK market
· Revenue: ₹15,967.57 million; Earnings: ₹1,009.45 million
· Management has invested in capacity expansion and backward integration
· Risk: Premium valuation with P/E above peer group, high-risk borrowings
Trident (NSEI: TRIDENT)
· Barnala-based textiles and paper group
· Major exporter of home textiles (towels, bedsheets, yarn)
· Full-year sales: ₹67,751.6 million; Net income: ₹3,771.1 million
· Already established relationships with UK retailers will translate directly into order flow
· Forecast earnings growth stronger than the broader Indian market
Other Textile Stocks in Focus:
· KPR Mill – ~15% of garment revenue from UK
· Welspun Living – Established UK business
· Indo Count – Strong UK presence
· Arvind Ltd – Elara Capital’s top pick, citing technical textiles and garment export growth
The Analyst View
Jhunjhunwala expects Indian textile companies to gain market share in the UK as tariff barriers are removed, with broader benefits from improving global market access, recovery in export demand, and a more competitive raw material environment supporting revenue growth and margins over the next few years. ICRA estimates benefits are likely to accrue from FY28 onwards, with an expected 10-15% revenue growth.
Sector 2: Gems & Jewellery – The Hidden Gem
The Numbers Tell the Story
Gems and jewellery represent one of India’s most under-penetrated export categories to the UK—and therefore one with the most upside.
· The UK imports jewellery worth $3 billion annually
· India exports only $400 million worth of jewellery to Britain annually
· That’s just 13% of the UK’s jewellery import market
· CETA eliminates duties of up to 4% on Indian jewellery entering the UK
The Growth Projection
Shaunak Parikh, Vice Chairman of the Gem and Jewellery Export Promotion Council (GJEPC), projects that improved market access and a level playing field will push gems and jewellery exports to the UK to around $2.5 billion.
The GJEPC has described the FTA as “far more than a tariff agreement—it is a growth agreement. It gives Indian jewellers a stronger foothold in a premium global market and enhances the competitiveness of ‘Made in India’ jewellery.”
What This Means for the Sector
The elimination of duties allows Indian jewellery manufacturers to compete more effectively in the premium UK market. Unlike textiles, where price competition is intense, jewellery offers higher margins and greater brand differentiation—making this a potentially more profitable export opportunity.
The agreement could also encourage greater investment and partnerships between Indian jewellery companies and British retailers.
Stocks to Watch
While gems and jewellery is dominated by unorganized players and SMEs, listed companies with export exposure include:
· Titan Company – Premium jewellery brand with growing international ambitions
· Kalyan Jewellers – Expanding footprint; UAE and UK exposure
· Rajesh Exports – Major gold jewellery exporter
Note: The gems and jewellery sector’s listed players are fewer and less directly UK-focused than textile companies, making the sector’s stock-market impact more diffuse but no less real for the industry as a whole.
Sector 3: Pharmaceuticals – The Long-Term Play
The Paradox of Indian Pharma in the UK
India is the “pharmacy of the world,” yet its presence in the UK market remains surprisingly small.
· India exported $25.8 billion worth of medicines worldwide
· India captured only about 3.2% of Britain’s pharmaceutical import demand
· The UK will eliminate tariffs of up to 8% on pharmaceutical products
The Real Barrier: Regulation, Not Tariffs
Here’s the critical insight: regulatory approvals, not tariffs, are the bigger constraint for Indian pharma in the UK. Unlike textiles, where tariff elimination immediately improves price competitiveness, pharma exports require:
· UK regulatory approval (MHRA authorization)
· Compliance with British Good Manufacturing Practices (GMP)
· Clinical trial data and bioequivalence studies
· Supply chain certification and traceability
As GTRI has noted, “Pharmaceuticals present a similar story: India exported $25.8 billion worth of medicines worldwide but captured only about 3.2% of Britain’s import demand, with regulatory approvals rather than tariffs seen as the bigger constraint.”
What CETA Changes
While CETA doesn’t immediately solve the regulatory bottleneck, it removes the tariff disadvantage that previously compounded the regulatory challenge. Indian pharma companies now compete on price parity with European suppliers, making regulatory approval a more worthwhile investment.
The agreement also signals deeper UK-India cooperation in healthcare and life sciences, potentially paving the way for regulatory recognition or mutual acceptance over time.
Stocks to Watch
Large-cap Indian pharma companies with UK aspirations:
· Sun Pharma – Global generics leader
· Dr. Reddy’s Laboratories – Strong UK presence
· Lupin – Growing European footprint
· Cipla – Expanding in developed markets
· Biocon – Biosimilars and research-driven exports
5 Best Stocks: Simple Analysis & Comparison
Based on the immediate CETA impact, here are five stocks positioned to benefit most from the India-UK trade pact:
| Stock | Sector | Financial Report |
|---|---|---|
| S.P. Apparels | Textiles (Apparel) | Revenue ₹15,967M; Earnings ₹1,009M |
| Trident | Textiles (Home) | Sales ₹67,752M; Net Income ₹3,771M |
| KPR Mill Textiles | Textiles (Apparel) | Growing garment exports |
| Welspun Living | Textiles (Home) | Part of Welspun Group |
| Titan Company | Gems & Jewellery | Market leader in Indian jewellery |
Analyst Consensus
Elara Capital has identified Arvind Ltd as a top pick in the textile space, citing growth opportunities in technical textiles and expanding garment exports. The firm also remains positive on home textile exporters such as Indo Count and Welspun Living, as well as apparel manufacturers KPR Mill and SP Apparels.
Beyond the Headlines: What Smart Investors Are Watching
- The Order Surge Is Real
Ahead of the July 15 implementation, Indian exporters are already reporting a significant surge in UK orders. Textile and garment exporters are seeing 12% higher orders than last year. This isn’t speculation—it’s real commercial activity.
- The China+1 Factor
Global sourcing diversification away from China remains a powerful tailwind for Indian exporters. CETA positions India as a more attractive alternative to Chinese suppliers for UK buyers, particularly in textiles and apparel.
- The EU Trade Deal Pipeline
The India-UK FTA and potential EU trade deals remain key structural tailwinds for Indian exporters. Success with the UK could accelerate negotiations with the European Union.
- Implementation Is Everything
As GTRI founder Ajay Srivastava put it: “The agreement opens the door; India must now convert access into exports.”. The real test of CETA will be whether Indian exporters can meet tougher regulatory standards and improve competitiveness.
Conclusion
CETA represents a structural shift in India-UK trade relations, not a one-time event. For textiles, the benefit is immediate and measurable—tariffs of up to 12% disappear overnight. For gems and jewellery, the opportunity is vast but will take time to materialize as supply chains adjust. For pharmaceuticals, the tariff relief is welcome, but regulatory alignment remains the bigger prize.
The immediate winners are clear: textile exporters with existing UK relationships, particularly S.P. Apparels and Trident, stand to gain first and fastest. Gems and jewellery exporters are poised for multi-year growth as they capture a larger share of the $3 billion UK market. Pharmaceutical companies will benefit from improved competitiveness, though the real payoff depends on regulatory progress.
For SME exporters, CETA levels the playing field but raises the stakes. Tariff advantages must be matched with quality, sustainability, and delivery reliability to convert access into actual orders.
For investors, the trade pact creates a multi-year thematic opportunity—but selectivity matters. Companies with established UK relationships, strong balance sheets, and the capacity to meet British quality standards are best positioned to convert CETA’s promise into sustained earnings growth.
Disclaimer:
This article is for informational purposes only and does not constitute financial advice. Please consult a qualified financial advisor before making investment decisions.
Sources:
PIB Press Release, Business Standard, Financial Express, Economic Times, CNBC TV18, Moneycontrol, Simply Wall St, GTRI Reports, GJEPC, ICRA, Elara Capital Research
Frequently Asked Questions
CETA and its companion social-security pact, the Double Contribution Convention, both enter into force on July 15, 2026, about a year after being signed in London on July 24, 2025.
It means the UK is removing tariffs on roughly 99% of its tariff lines for Indian goods, covering nearly 99% of India’s export value to Britain. The actual size of the cut ranges from 2.5% on jewellery to as high as 70% on some processed foods, so the real-world benefit differs a lot by sector.
Textiles, garments, leather, footwear and marine products see the fastest impact because they carried the steepest tariff disadvantage against duty-free rivals like Bangladesh and Vietnam. Gems & jewellery follows closely. Pharma and chemicals benefit too, but more gradually, since UK regulatory approvals matter more there than the tariff cut itself.
From July 15, exporters can self-certify their goods’ origin through an “origin declaration” instead of applying for a government-issued Certificate of Origin for every shipment. They still need to clear a Qualifying Value Content threshold (typically 35-45%, depending on the method) and keep supporting documents for five years in case customs asks for proof.
For export-oriented textile, jewellery and select pharma companies with genuine UK exposure, yes, it’s a real structural tailwind. But several stocks already rallied in June when the July 15 date was first confirmed, so it’s worth watching valuations rather than assuming a fresh rally just because the deal is finally live.
Leave a Reply